Kailera Therapeutics, Inc. ($KLRA)
Filing Information
| Accession Number | 0001193125-26-164388 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 20, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
44,151,024
Total Value
$134,375,008.00
P&L
+52.6% (+$70,637,725.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 20, 2026 | Conversion | 17,857,143 | โ | โ | 17,857,143 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Apr 20, 2026 | Purchase | 8,398,438 | $16.00 | $134,375,008.00 | 26,255,581 | Indirect | See footnotes | View Details | |
Director | Series B Preferred Stock | Derivative | Apr 20, 2026 | Conversion | 17,857,143 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details | |
Director | Stock Option (right to buy) | Derivative | Apr 16, 2026 | Grant/Award | 38,300 | $0.00 | $0.00 | 38,300 | Direct | โ | View Details |